Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New sensor aims to help doctors see inside arteries during procedures

NCT ID NCT06112054

Knowledge-focused Sponsor: Sensome Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a special guidewire with a sensor that measures electrical properties of tissues in people with peripheral artery disease. The goal was to see if the sensor could tell the difference between various tissues, like the artery wall and surrounding areas. Nineteen participants were included, and the study focused on whether the device could successfully take these measurements during standard procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Clotild Smart Guidewire System (CSGS) - a device with an impedance sensor
What this could lead to
If successful, this sensor could help doctors better identify different tissues during artery procedures, potentially improving treatment accuracy.
What could go wrong
This was a very small, early feasibility study with only 19 participants. It only tested if the sensor could take measurements, not if it improves patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

19 people

The number who actually took part.

Started

Nov 2023

Finished

Aug 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 18 years * Subjects with acute and chronic occlusions in the arteries of the lower limbs * Patients eligible for endovascular interventional procedures * Written Informed Consent to participate in the study. Exclusion Criteria: * Target Vessel Aneurysm * Target vessel diameter \<2mm * Lesions starting at the Common Iliac Artery * Any subject that is, according to the discretion of the investigator, not eligible for study participation * Known lactating or confirmation of positive pregnancy test according to site specific standard of care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

peripheral arterial disease peripheral vascular disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Peripheral vascular disease

Contacts and locations

Locations

  • AZ Sint Blasius

    Dendermonde, 9200, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.